Form 4: Xtant Medical CFO's RSU Vesting & Tax Withholding

Xtant Medical Holdings, Inc. CFO Scott C. Neils reported the withholding of 34,131 shares to cover tax obligations upon the vesting of restricted stock units.

Summary

• CFO Scott C. Neils reported a transaction involving Xtant Medical Holdings, Inc. common stock.
• 34,131 shares were withheld by the Issuer to satisfy tax withholding obligations related to the vesting and settlement of restricted stock unit awards.
• The transaction occurred on August 15, 2025, with a price of $0.63 per share for the withheld shares.
• Following this transaction, Scott C. Neils beneficially owns 588,174 shares of common stock.
• This beneficial ownership includes 235,623 shares issuable upon vesting and settlement of restricted stock unit awards or deferred stock unit awards granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan.
• It also includes 85,220 shares issuable upon vesting and settlement of restricted stock unit awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan.
• The vesting of these units is conditioned upon the CFO remaining an employee of Xtant through the respective vesting dates.

Sentiment

Score: 6

Explanation: The filing reports a routine insider transaction related to equity compensation. While it involves a reduction in direct share count due to tax withholding, it signifies the vesting of previously granted awards, which is a positive for executive retention and alignment. It's a neutral to slightly positive event as it confirms the compensation structure is functioning as intended.

Positives

• The transaction is a routine tax withholding event, indicating the vesting of previously granted equity awards, which aligns management's interests with shareholders.
• CFO Scott C. Neils continues to hold a significant beneficial ownership of 588,174 shares, demonstrating continued alignment with company performance.

Negatives

• 34,131 shares were effectively 'sold' back to the company to cover taxes, reducing the CFO's direct share count, though this is a standard practice for RSU vesting.

Risks

• The beneficial ownership of 320,843 shares (235,623 + 85,220) is contingent on the CFO remaining an employee through the respective vesting dates, posing a retention risk for key management.

Future Outlook

The filing indicates future vesting of restricted stock units and deferred stock units, contingent on the CFO's continued employment, suggesting a long-term retention strategy for key management.

Industry Context

This is a routine insider transaction (Form 4) related to equity compensation. It does not provide broader industry trends or competitive analysis. It's a standard compensation event.

Comparison to Industry Standards

• This is a standard Form 4 filing for an insider transaction related to RSU vesting and tax withholding. Such transactions are common across publicly traded companies that use equity compensation. There are no specific comparable companies, projects, or results mentioned in the filing to assess against.

Stakeholder Impact

• Shareholders: Provides transparency on executive equity ownership and compensation. The withholding for taxes is a standard practice and does not indicate a lack of confidence.
• Employees: Reinforces the company's use of equity compensation plans to incentivize and retain key personnel.

Next Steps

• Continued vesting of restricted stock units and deferred stock units for the reporting person, contingent on continued employment.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction where shares were withheld to cover tax obligations upon the vesting of restricted stock units for the CFO. This is a standard event for executives with equity compensation and does not indicate any change in the company's fundamentals or strategic direction. While it shows a reduction in direct share count, it confirms the vesting of previously granted awards, which is a positive for executive retention and alignment. As such, it provides no new information that would warrant a change in investment thesis, thus a 'hold' recommendation is appropriate.

Keywords

Xtant Medical Holdings, XTNT, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Tax Withholding, Equity Incentive Plan, CFO, Scott C. Neils